IL10 and neoplasm: Tumor cells that can reduce their immunogenicity through immunoediting survive or produce certain negative regulators including PD-L1 on tumor cells, interleukin-10 (IL-10), transforming growth factor β (TGF-β), regulatory T cells (Tregs), and myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment (TME).